2-(4-氯-2-硝基苯基)基丙二酸二甲酯 | 147124-32-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(4-氯-2-硝基苯基)基丙二酸二甲酯
• 中文别名: 2-(4-氯-2-硝基苯基)丙二酸二甲酯
• 英文名称: dimethyl 2-(4-chloro-2-nitrophenyl)malonate
• 英文别名: dimethyl (4-chloro-2-nitrophenyl)malonate；dimethyl 2-(4-chloro-2-nitrophenyl)propanedioate
• CAS: 147124-32-1
• 化学式: C₁₁H₁₀ClNO₆
• 分子量: 287.656
• InChiKey: XNQGJNNDVKLNQO-UHFFFAOYSA-N

物化性质

• 熔点：
  83-85°
• 沸点：
  387.1±37.0 °C(Predicted)
• 密度：
  1.415±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  98.4
• 氢给体数：
  0
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2917399090
• 储存条件：
  室温密封，干燥保存。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Dimethyl 2-(4-chloro-2-nitrophenyl)malonate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Dimethyl 2-(4-chloro-2-nitrophenyl)malonate
CAS number: 147124-32-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H10ClNO6
Molecular weight: 287.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(4-氯-2-硝基苯基)基丙二酸二甲酯 在 盐酸 、 aluminum (III) chloride 、 tin 、 sodium carbonate 、 三氟乙酸 作用下， 以 甲醇 、 水 、 1,2-二氯乙烷 为溶剂， 反应 0.25h， 生成 齐拉西酮
  参考文献：
  名称：

  [EN] A SHORT PROCESS FOR THE PREPARATION OF ZIPRASIDONE AND INTERMEDIATES THEREOF
  [FR] PROCÉDÉ COURT POUR LA PRÉPARATION DE ZIPRASIDONE ET DE SES INTERMÉDIAIRES

  摘要：

  一种制备氧化吲哚衍生物（盐酸齐拉西酮）的方法，包括将式（II）的化合物与金属或金属化合物矿酸反应，以一步得到式（III）的化合物，该化合物转化为式IV的化合物，后者是制备式（I）的化合物的关键中间体。

  公开号：

  WO2012020424A1
• 作为产物：
  描述：

  丙二酸二甲酯 、 2,5-二氯硝基苯 在 sodium hydride 作用下， 生成 2-(4-氯-2-硝基苯基)基丙二酸二甲酯
  参考文献：
  名称：

  A General Oxindole Synthesis

  摘要：

  一种针对吲哚-2(3H)-酮（氧吲哚）的整体合成方法被开发，该方法基于二甲基马来酸酯与可商业获得的卤代硝基苯的加成。这条路线相较于许多其他氧吲哚合成方法的优势在于对芳香环取代模式的区域化学控制。

  DOI：

  10.1055/s-1993-25790

文献信息

• A Unified Catalytic Asymmetric (4+1) and (5+1) Annulation Strategy to Access Chiral Spirooxindole‐Fused Oxacycles
  作者：Min Gao、Yanshu Luo、Qianlan Xu、Yukun Zhao、Xiangnan Gong、Yuanzhi Xia、Lin Hu

  DOI：10.1002/anie.202105282

  日期：2021.9

  A unified catalytic asymmetric (N+1) (N=4, 5) annulation reaction of oxindoles with bifunctional peroxides has been achieved in the presence of a chiral phase-transfer catalyst (PTC). This general strategy utilizes peroxides as unique bielectrophilic four- or five-atom synthons to participate in the C−C and the subsequent umpolung C−O bond-forming reactions with one-carbon unit nucleophiles, thus providing

  在手性相转移催化剂 (PTC) 的存在下，已经实现了羟吲哚与双官能过氧化物的统一催化不对称 ( N +1) ( N =4, 5) 环化反应。这种通用策略利用过氧化物作为独特的双亲电四原子或五原子合成子参与 C−C 和随后与单碳单元亲核试剂的 umpolung C−O 键形成反应，从而提供了一种独特的方法来获得有价值的手性螺吲哚-四氢呋喃和-四氢吡喃在温和条件下具有良好的产率和高对映选择性。进行 DFT 计算以合理化高对映选择性的起源。还证明了所得产物的克级合成和合成效用。
• 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex
  作者：Michael Rowley、Paul D. Leeson、Graeme I. Stevenson、Angela M. Moseley、Ian Stansfield、Ian Sanderson、Lesley Robinson、Raymond Baker、John A. Kemp

  DOI：10.1021/jm00074a020

  日期：1993.10

  receptor contain a carboxylic acid, which we believe to be detrimental to penetration of the blood-brain barrier. By consideration of a pharmacophore, novel antagonists at this site have been designed in which the anionic functionality is a vinylogous acid, in the form of a 4-hydroxyquinolin-2(1H)-one. In this series, a 3-substituent is necessary for binding, and correct manipulation of this group leads

  NMDA受体的甘氨酸位点上的大多数完全拮抗剂都包含一种羧酸，我们认为这对血脑屏障的渗透是有害的。通过考虑药效基团，已经设计了该位点的新型拮抗剂，其中阴离子官能团是4-羟基喹啉-2（1H）-一形式的乙烯基次糖基酸。在该系列中，结合需要使用3个取代基，并且对该基团的正确操作会导致生成化合物，例如3-（3-羟苯基）炔丙基酯24（L-701,273），其IC50取代[3H] -L-689,560在1.39 microM的皮质切片中结合0.17 microM和Kb与NMDA结合。测试化合物在DBA / 2小鼠中预防音源性癫痫发作的能力。该系列中最有效的化合物是环丙基酮42（L-701,252），ED50为4。1 mg / kg腹腔注射。提出了与甘氨酸位点结合的模型，其中重要的相互作用是推定的受体阳离子与3-取代基的pi-系统。
• Concise Syntheses of the Cruciferous Phytoalexins Brassilexin, Sinalexin, Wasalexins, and Analogues:  Expanding the Scope of the Vilsmeier Formylation
  作者：M. Soledade C. Pedras、Mukund Jha

  DOI：10.1021/jo0479866

  日期：2005.3.1

  the Vilsmeier formylation to indoline-2-thiones followed by a new aqueous ammonia workup procedure. Similarly, a very concise two-pot synthesis of the phytoalexins wasalexins using sequential formylation−amination of indolin-2-ones is described. Remarkably, this novel aqueous ammonia workup allows the sequential one-pot formylation−amination, expanding substantially the scope of the Vilsmeier formylation

  通过将Vilsmeier甲酰化应用到二氢吲哚-2-硫酮上，然后进行新的氨水后处理程序，证明了植物抗毒素黄铜素，芥辣素和类似物的有效合成。类似地，描述了使用顺式吲哚-2-酮的甲酰化-氨化非常精确的两锅合成植物抗毒素wasalexins。引人注目的是，这种新颖的氨水后处理允许顺序进行一锅甲酰化氨化反应，从而大大扩大了吲哚啉-2-硫酮和吲哚-2-酮的维尔斯迈尔甲酰化作用的范围。据报道，甲酰化-胺化反应的检查和条件的优化，以及几种黄铜蛋白类似物的合成和抗真菌活性。
• [EN] 2-(1H-INDAZOL-6-YLAMINO)-BENZAMIDE COMPOUNDS AS PROTEIN KINASES INHIBITORS USEFUL FOR THE TREATMENT OF OPHTALMIC DISEASES<br/>[FR] COMPOSES DE 2-(1H-INDAZOL-6-YLAMINO)-BENZAMIDES EN TANT QU'INHIBITEURS DE PROTEINES KINASES UTILES POUR LE TRAITEMENT DE MALADIES OPHTALMIQUES
  申请人：PFIZER

  公开号：WO2004056806A1

  公开（公告）日：2004-07-08

  Indazole compounds that modulate and/or inhibit the ophthalmic diseases and the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating ophthalmic diseases and cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma,rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

  描述了可以调节和/或抑制眼科疾病和某些蛋白激酶活性的吲哚唑化合物。这些化合物和含有它们的药物组合物能够介导酪氨酸激酶信号传导，从而调节和/或抑制不需要的细胞增殖。该发明还涉及含有这些化合物的药物组合物的治疗或预防用途，以及通过给予这些化合物的有效剂量来治疗眼科疾病和癌症以及与不需要的血管生成和/或细胞增殖相关的其他疾病状态，如糖尿病视网膜病变、新生血管性青光眼、类风湿性关节炎和牛皮癣。
• 一种奇拉西酮中间体的制备方法
  申请人：浙江美诺华药物化学有限公司

  公开号：CN105753765A

  公开（公告）日：2016-07-13

  本发明涉及一种奇拉西酮中间体的制备方法，这是一种一锅法制备6?氯?2?吲哚酮的方法，制备过程中用价格便宜的碱液和相转移催化剂代替现有技术中必须使用且价格昂贵的氢化钠，用可回收的低级脂肪酮和低级脂肪醇代替不易回收的DMF和DMSO，大大降低了成本，且所使用的原料便宜易得、工艺简单易行，简化了后处理步骤，特别是步骤(1)不需任何洗涤、萃取、纯化操作，可直接进行一个步骤，整个操作步骤中无需使用柱色谱纯化，使整个制备方法工艺简化，便于实现工业化；本发明在合成式Ⅲ化合物的过程中，脱酸工艺温和、安全；在合成式Ⅱ化合物时采用低价态含硫化合物还原，避免了大量废酸液的产生，不仅生产安全、对环境无污染，也使制备过程简便易行。